Application for quotation of securities - EMD

Dear Investors,

Emyria Limited has recently announced the quotation of 120,206,872 fully paid ordinary shares (ASX code EMD) as part of a transaction previously disclosed in an Appendix 3B. This issuance, dated June 26, 2025, is part of the company's efforts to raise $2,884,965 through tranche 1 placement shares. The issue price per security is set at AUD 0.02400000, denominated in Australian Dollars.

Following this quotation, Emyria's total issued capital will consist of 611,451,030 fully paid ordinary shares on the ASX, denoted by the code EMD. Additionally, the company retains 7,000,000 unquoted option securities and various other unquoted securities for strategic purposes.

We encourage investors to review the full details of this announcement on our website and welcome any inquiries or clarifications you may have regarding this transaction or our ongoing initiatives. Your trust and support are fundamental to our growth and commitment to advancing patient outcomes in neuroscience and mental health.

Thank you for your continued interest and investment in Emyria Limited.

Warm regards,

[Management Team]